カテゴリ： MarketLine, イギリス, 企業調査

Vodafone Group Plc：戦略・SWOT・企業財務分析

◆英語タイトル：Vodafone Group Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015252
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：通信・IT
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Vodafone Group Plc – Strategy, SWOT and Corporate Finance Report
Summary

Vodafone Group Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vodafone Group Public Limited Company (Vodafone or “the group”) is a telecommunications company providing a range of services, including voice, messaging, data and fixed broadband. The group operates in Europe, and Africa, Middle East, and Asia Pacific (AMAP). It is headquartered in Berkshire, the UK and employed 111,684 people as of March 31, 2016.

Scope

- Detailed information on Vodafone Group Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vodafone Group Plc in the form of a SWOT analysis
- An in-depth view of the business model of Vodafone Group Plc including a breakdown and examination of key business segments
- Intelligence on Vodafone Group Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vodafone Group Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vodafone Group Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vodafone Group Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vodafone Group Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Vodafone Group Plc: Company Overview
Vodafone Group Plc: Overview and Key Facts
Vodafone Group Plc: Overview
Vodafone Group Plc: Key Facts
Vodafone Group Plc: Key Employees
Vodafone Group Plc: Key Employee Biographies
Vodafone Group Plc: Major Products and Services
Vodafone Group Plc: Company History
Vodafone Group Plc: Management Statement
Vodafone Group Plc: Locations and Subsidiaries
Vodafone Group Plc: Key Competitors
Vodafone Group Plc: Company Analysis
Vodafone Group Plc: Business Description
Vodafone Group Plc: SWOT Analysis
Vodafone Group Plc: SWOT Overview
Vodafone Group Plc: Strengths
Vodafone Group Plc: Weaknesses
Vodafone Group Plc: Opportunities
Vodafone Group Plc: Threats
Vodafone Group Plc: Corporate Financial Deals Activity
Vodafone Group Plc: Financial Deals Overview
Vodafone Group Plc: Targets and Partners
Vodafone Group Plc: Top Deals 2013 – 2017YTD*
Vodafone Group Plc: Advisors
Vodafone Group Plc: Top Legal Advisors
Vodafone Group Plc: Top Financial Advisors
Vodafone Group Plc: Mergers and Acquisitions
Vodafone Group Plc: Capital Raising
Vodafone Group Plc: Partnership
Vodafone Group Plc: Divestments
Vodafone Group Plc: Recent Developments
Vodafone Group Plc: News and Events Summary
Vodafone Group Plc: Contracts
Vodafone Group Plc: Financial Deals
Vodafone Group Plc: IT Spending Announcements
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Vodafone Group Plc: Key Facts
Table 2: Vodafone Group Plc: Key Employees
Table 3: Vodafone Group Plc: Locations and Subsidiaries
Table 4: Vodafone Group Plc: Key Competitors
Table 5: Vodafone Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vodafone Group Plc: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Vodafone Group Plc: M&A Average Deal Size - Value (US$m)
Table 8: Vodafone Group Plc: Targets and Partners
Table 9: Vodafone Group Plc: Top Deals 2013 - 2017YTD*
Table 10: Vodafone Group Plc: Legal Advisor Ranking by Value (US$m)
Table 11: Vodafone Group Plc: Financial Advisor Ranking by Value (US$m)
Table 12: Vodafone Group Plc: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: Vodafone Group Plc: M&A Activity by Geography (2013 - YTD*2017)
Table 14: Vodafone Group Plc: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 15: Vodafone Group Plc: Capital Raising by Deal Type (2013 - YTD*2017)
Table 16: Vodafone Group Plc: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 17: Vodafone Group Plc: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 18: Vodafone Group Plc: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 19: Vodafone Group Plc: Divestments by Geography (2013 - YTD*2017)
Table 20: Vodafone Group Plc: News and Events Summary
Table 21: Vodafone Group Plc: Contracts
Table 22: Vodafone Group Plc: Financial Deals
Table 23: Vodafone Group Plc: IT Spending Announcements

★海外企業調査レポート[Vodafone Group Plc：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bayer AG (BAYN)-製薬・医療分野：企業M&A・提携分析
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, oncology, hematology, ophthalmology, infection and other indicat …
  • Toei Animation Co., Ltd. (4816)：企業の財務・戦略的SWOT分析
    Toei Animation Co., Ltd. (4816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SRF Ltd (SRF)：企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • CSG Systems International Inc (CSGS)：企業の財務・戦略的SWOT分析
    CSG Systems International Inc (CSGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AB Volvo：戦略・SWOT・企業財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Epigenomics AG (ECX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Australia and New Zealand Banking Group Ltd：企業のM&A・事業提携・投資動向
    Australia and New Zealand Banking Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Australia and New Zealand Banking Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • DiGi.Com Berhad (DIGI)：企業の財務・戦略的SWOT分析
    DiGi.Com Berhad (DIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Veristat LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers services such as clinical project management, data management, clinical monitoring, biostatistics, medical writing, project management, reg …
  • Mitsui O.S.K. Lines, Ltd.：企業の戦略・SWOT・財務分析
    Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Zhuhai Zhongfu Enterprise Company Limited：企業の戦略・SWOT・財務情報
    Zhuhai Zhongfu Enterprise Company Limited - Strategy, SWOT and Corporate Finance Report Summary Zhuhai Zhongfu Enterprise Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Taylor Communications Inc：企業の戦略的SWOT分析
    Taylor Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Saladax Biomedical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Centre for Drug Design and Discovery：製薬・医療：M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • NGK Insulators Ltd (5333)：企業の財務・戦略的SWOT分析
    NGK Insulators Ltd (5333) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Republic Services, Inc.：企業の戦略・SWOT・財務情報
    Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lakeland Financial Corporation：企業の戦略・SWOT・財務情報
    Lakeland Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Lakeland Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Luye Pharma Group Ltd (2186)：企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma), a subsidiary of Luye Life Sciences Group Ltd is a drug development company that discovers, manufactures, and commercializes novel formulations, generic drugs, and pharmaceutical products. The company offers its products in the form of tablets, formulation …
  • Valvoline Inc (VVV)：企業の財務・戦略的SWOT分析
    Valvoline Inc (VVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Miromatrix Medical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company engaged in the development extracellular matrix based medical devices in soft tissue reinforcement and advanced wound care. The company offers MIRODERM a porcine liver-derived noncrosslinked acellular biologic wound matri …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆